A female patient is receiving chemotherapy to cure non-small cell lung cancer. She presents to the infusion clinic and is scheduled to receive both agents today. In the past, the patient has received chemotherapy regimens containing erlotinib, etoposide, docetaxel and gemcitabine.
Chemotherapy regimen:
Cisplatin 100 mg/m² IV Q4weeks
Vinorelbine 25 mg/m² IV weekly
This patient will be given an antiemetic regimen 30 minutes prior to the chemotherapy infusions. Which of the following combinations is appropriate?
A. Aprepitant + Dexamethasone + Ondansetron
B. Aprepitant + Prednisone + Compazine
C. Aprepitant + Methylprednisolone + Compazine
D. Aprepitant + Methylprednisolone + Metoclopramide
E. Aprepitant + Prednisone + Lorazepam
